AstraZeneca competitorsClear all

AstraZeneca's top competitors include Daiichi Sankyo, Boehringer Ingelheim, Sanofi, Novartis, GSK, Amgen, Bayer, Bristol-Myers Squibb and Teva Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Daiichi Sankyo
Daiichi Sankyo
Daiichi Sankyo is a developer of pharmaceutical products.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date
Founding Date
1999
Founding Date
2005
Founding Date
1885
Founding Date
2004
Founding Date
1996
Founding Date
2000
Founding Date
1980
Founding Date
1863
Founding Date
1887
Founding Date
1901
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
Chuo City, JP HQ
Wien, AT
Braine L'alleud, BE
São Paulo, BR
Beijing, CN
Shanghai, CN
Shanghai, CN
see more
Locations
Ingelheim am Rhein, DE HQ
Algiers, DZ
Munro, AR
North Ryde, AU
Vienna, AT
Minsk, BY
Elsene, BE
see more
Locations
Paris, FR HQ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
Zaventem, BE
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Brentford, GB HQ
Boudouaou, DZ
San Fernando, AR
Abbotsford, AU
Boronia, AU
Wien, AT
Minsk, BY
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Leverkusen, DE HQ
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
see more
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
Rueil Malmaison, FR
see more
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Minsk, BY
Antwerpen, BE
São Paulo, BR
Dupnica, BG
see more
Employees
Employees
76,1008% increase
Employees
16,033
Employees
51,9442% increase
Employees
100,4094% decrease
Employees
105,7942% increase
Employees
99,4374% increase
Employees
24,3004% increase
Employees
101,1683% decrease
Employees
30,00029% increase
Employees
37,1007% decrease
Valuation ($)
Valuation ($)
150.7 b
Valuation ($)
35.1 b
Valuation ($)
N/A
Valuation ($)
129.4 b
Valuation ($)
N/A
Valuation ($)
97.9 b
Valuation ($)
140.3 b
Valuation ($)
58.6 b
Valuation ($)
155.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
283.7 k
Twitter followers
580
Twitter followers
101.3 k
Twitter followers
142.1 k
Twitter followers
292.9 k
Twitter followers
225.6 k
Twitter followers
100.3 k
Twitter followers
178.7 k
Twitter followers
151.9 k
Twitter followers
3.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
41
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
34
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
75
Number of tweets (last 30 days)
88
Number of tweets (last 30 days)
59
Number of tweets (last 30 days)
32
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
40.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9.7
Average likes per tweet (last 30 days)
20.4
Average likes per tweet (last 30 days)
11.4
Average likes per tweet (last 30 days)
19.8
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
11.7
Average likes per tweet (last 30 days)
8.6
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
97.06%
Percentage of tweets with engagement (last 30 days)
95.45%
Percentage of tweets with engagement (last 30 days)
66.67%
Percentage of tweets with engagement (last 30 days)
89.33%
Percentage of tweets with engagement (last 30 days)
94.32%
Percentage of tweets with engagement (last 30 days)
50.85%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
57766
Alexa Website Rank
240801
Alexa Website Rank
192222
Alexa Website Rank
123373
Alexa Website Rank
88970
Alexa Website Rank
58088
Alexa Website Rank
200877
Alexa Website Rank
85997
Alexa Website Rank
101235
Alexa Website Rank
398088
Employee Rating
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
4.2
Employee Rating
3.3
Employee Rating
4.2
Employee Rating
3.8
Employee Rating
4
Employee Rating
N/A
Employee Rating
4
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
$24.4b (FY, 2019)
Revenue (est.)
¥981.8b (FY, 2019)
Revenue (est.)
€21.3b (FY, 2019)
Revenue (est.)
€36b (FY, 2020)
Revenue (est.)
$48.7b (FY, 2020)
Revenue (est.)
£33.8b (FY, 2019)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
€43.5b (FY, 2019)
Revenue (est.)
$42.5b (FY, 2020)
Revenue (est.)
$16.7b (FY, 2020)
Cost of goods
Cost of goods
$4.9b (FY, 2019)
Cost of goods
¥343.2b (FY, 2019)
Cost of goods
€7.3b (FY, 2019)
Cost of goods
€12.2b (FY, 2020)
Cost of goods
$15.1b (FY, 2020)
Cost of goods
£11.9b (FY, 2019)
Cost of goods
$6.2b (FY, 2020)
Cost of goods
€17.5b (FY, 2019)
Cost of goods
$11.8b (FY, 2020)
Cost of goods
$8.9b (FY, 2020)
Gross profit
Gross profit
$19.5b (FY, 2019)
Gross profit
¥638.6b (FY, 2019)
Gross profit
€14b (FY, 2019)
Gross profit
€25.2b (FY, 2020)
Gross profit
$33.5b (FY, 2020)
Gross profit
£21.9b (FY, 2019)
Gross profit
$19.3b (FY, 2020)
Gross profit
€26.1b (FY, 2019)
Gross profit
$30.7b (FY, 2020)
Gross profit
$7.7b (FY, 2020)
Net income
Net income
$1.2b (FY, 2019)
Net income
¥129b (FY, 2019)
Net income
€2.7b (FY, 2019)
Net income
€12.4b (FY, 2020)
Net income
$8.1b (FY, 2020)
Net income
£5.3b (FY, 2019)
Net income
$7.3b (FY, 2020)
Net income
€2.4b (FY, 2019)
Net income
($9b) (FY, 2020)
Net income
($4.1b) (FY, 2020)

Operating

Countries
Countries
100 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
153 (FY, 2018)
Countries
N/A
Countries
N/A
Facilities
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
180 (FY, 2020)
Facilities
N/A
Facilities
N/A
Facilities
90 (FY, 2019)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
13 (Dec, 2020)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
7 (FY, 2019)
Manufacturing Facilities
N/A
Patent Applications
Patent Applications
N/A
Patent Applications
415 (Dec, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
48.1 k (FY, 2017)
Patent Applications
N/A
Patent Applications
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
16 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
12 (FY, 2019)
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
12 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
19 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
7 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
6 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
14 (FY, 2019)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
7 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
44 (Q4, 2020)
Phase III Trials Products
14 (FY, 2019)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
22 (Q4, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
9 (FY, 2019)
Phase III Trials Products (Oncology)
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
171 (FY, 2020)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
68 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A

Funding

Total funding raised
Total funding raised
$ 1b
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 310m
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
$ 15.5m
Total funding raised
$ 358m
For sources of this data, please see the company profile

View company profiles

Daiichi Sankyo
HQ
Chuo City, JP
Employees
16,033

Daiichi Sankyo is a developer of pharmaceutical products.

View company
Boehringer Ingelheim
HQ
Ingelheim am Rhein, DE
Employees
51,944↑ 2% increase

Boehringer Ingelheim a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.

View company
Sanofi
HQ
Paris, FR
Employees
100,409↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company
Novartis
HQ
Basel, CH
Employees
105,794↑ 2% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company